.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Chubb
Teva
Chinese Patent Office
Harvard Business School
Express Scripts
McKinsey
AstraZeneca
Merck

Generated: November 24, 2017

DrugPatentWatch Database Preview

Zydus Pharms Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA INC, and what generic and branded alternatives to ZYDUS PHARMS USA INC drugs are available?

ZYDUS PHARMS USA INC has one hundred and sixteen approved drugs.

There are eight tentative approvals on ZYDUS PHARMS USA INC drugs.

Summary for Zydus Pharms Usa Inc

US Patents:0
Tradenames:102
Ingredients:103
NDAs:116
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
PIOGLITAZONE HYDROCHLORIDE
pioglitazone hydrochloride
TABLET;ORAL202456-003Feb 13, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
TOPIRAMATE
topiramate
TABLET;ORAL078235-001Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DIPYRIDAMOLE
dipyridamole
TABLET;ORAL040874-003Jan 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
GLYBURIDE
glyburide
TABLET;ORAL206749-003May 10, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079017-005Sep 17, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ELETRIPTAN HYDROBROMIDE
eletriptan hydrobromide
TABLET;ORAL206409-002Jun 16, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL090728-002Jan 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
TELMISARTAN
telmisartan
TABLET;ORAL203325-001Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ROPINIROLE HYDROCHLORIDE
ropinirole hydrochloride
TABLET;ORAL090411-003Jun 1, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL091390-004Aug 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ZYDUS PHARMS USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Colorcon
Novartis
Cantor Fitzgerald
QuintilesIMS
Chubb
Citi
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot